Otsuka Pharmaceutical Co., Ltd.
Phone: +81367171400
Fax: +81 3 6717 1499
Web: https://www.otsuka.co.jp/en/
| Native name | 大塚製薬株式会社 |
|---|---|
| Romanized name | Ōtsuka Seiyaku Kabushiki-gaisha |
| Type | Public KK |
| Traded as | TYO: 4578 TOPIX 100 Component |
| Industry | Pharmaceutical |
| Founded | 1921 (Originally founded), 1964 (Current corporation) |
| Founder | Busaburo Otsuka |
| Headquarters | Chiyoda, Tokyo, Japan |
| Number of locations | 69 |
| Area served | Worldwide |
| Key people | Tatsuo Higuchi (President) |
| Revenue | ¥ 531.2 billion (2017) |
| Operating income | ¥ 57.0 billion (2017) |
| Owner | Nomura Trust and Banking investment trusts (11.43%) and investment trusts managed by other banks |
| Number of employees | 5,634 (2017) |
| Parent | Otsuka Holdings Co. Ltd |
| Website | otsuka.com |
Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社, Ōtsuka Seiyaku Kabushiki-gaisha) (TYO: 4578), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964.
For detailed contact information visit location pages below.
Otsuka Pharmaceutical Co., Ltd.'s locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Otsuka Pharmaceutical Co., Ltd.
-
Korea Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.Completato
-
Korea Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.Completato
-
Korea Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.CompletatoDisturbo di Tourette | Disturbo motorio cronico o tic vocaleCorea, Repubblica di
-
Korea Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.SconosciutoMucosite oraleCorea, Repubblica di
-
Otsuka Pharmaceutical Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.CompletatoLeucemia mieloide acutaTaiwan, Corea, Repubblica di, Giappone
-
Korea Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Co., Ltd.CompletatoTumore solidoCorea, Repubblica di
-
Otsuka Pharmaceutical Co., Ltd.Non ancora reclutamentoDermatite atopica (AD)Giappone
-
Otsuka Pharmaceutical Co., Ltd.ReclutamentoDisturbo da deficit di attenzione iperattività (ADHD)Giappone
-
Otsuka Pharmaceutical Co., Ltd.CompletatoColesterolemia da lipoproteine a iper-bassa densità (LDL).Giappone
-
Otsuka Pharmaceutical Co., Ltd.Attivo, non reclutanteMieloma multiplo (MM)Giappone